Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes

Research in Immunology

Volumn 149, Issue 7-8, 1998, Pages 681-684

  Leroy, P ^c   Slos, P ^c   Homann, H ^c   Erbs, P ^c   Poitevin, Y ^c   Regulier, E ^c   Colonna, F Q ^a   Devauchelle, P ^a   Roth, C ^b   Pavirani, A ^c   Mehtali, M ^c  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b INSTITUT PASTEUR   (France)

^c TRANSGENE S A   (France)

Author keywords

Animal models; In vivo gene transfer; MHC; Gene therapy; Review

Indexed keywords

INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS VECTOR;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; CANCER IMMUNOTHERAPY; CONFERENCE PAPER; GENE TARGETING; GENE TRANSFER; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; VERO CELL;

EID: 0032323227     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80038-8     Document Type: Conference Paper

References (18)

1. Chartier, C., Degryse, E., Gantzer, M., Dieterle, A.D., Pavirani, A. & Mehtali M., (1996), Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol., 70, 4805-4810.
2. Chen, L. (1998), Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol. Today, 19, 2730.
3. Chen, L., Linsley, P.S. & Hellström, K.E. (1993), Costimulation of T cells for tumor immunity. Immunol. Today, 14, 483-486.
4. Dranoff, G., Jaffe, E.M., Lazenby, A., Golumbeck, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D.M. & Mulligan, R.C. (1993), Vaccination with irradiated tumor cells engineered to secrete murine GMCSF stimulates potent, specific and long lasting antitumor immunity. Proc. Natl. Acad. Sci. USA, 90, 3539-3543.
5. Forni, G., Cavallo, F., Consalvo, M., Allione, A., Dellabone, P., Casorati, G. & Giovarelli, M. (1995), Molecular approaches to cancer immunotherapy. Cytokines Mol. Ther., 1, 225-248.
6. Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. (1977), Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36, 59-72.
7. Haddada, H., Ragot, T., Cordier, L., Duffour, M.T. & Perricaudet, M. (1993), Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum. Gene. Ther., 4, 703-711.
8. Harvey, H.J., MacEwen, E.G., Braun, D., Patnaik, A.K., Withrow, S.J. & Jongeward, S. (1981), Prognostic criteria for dogs with oral melanoma. J. Am. Vet. Med. Assoc., 178, 580-582.
9. Hock, H., Dorsch, M., Kunzendorf, U., Qin, Z., Diamenstein, T. & Blankenstein, T. (1993), Mechanisms of rejection induced by tumor cell-targeted gene transfer of Interleukin-2, Interleukin-4, Interleukin-7, tumor necrosis factor or Interferon gamma. Proc. Natl. Acad. Sci. USA, 90, 2774-2778.
10. Horwitz, M.S. (1990), Adenoviridae and their replication, in "Virology, 2nd Edition" (B.N. Fields et al.) (pp. 1679-1721). Raven Press Ltd, New York.
11. Quintin-Colonna, F., Devauchelle, P., Fradelizi, D., Mourot, B., Faure, T., Kourilsky, P., Roth, C. & Mehtali, M. (1996), Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human Interleukin-2. Gene Ther., 3, 1104-1112.
12. Roth, C., Mir, L., Cressent, M., Quintin-Colonna, F., Ley, V., Fradelizi, D. & Kourilsky, P. (1992), Inhibition of tumor growth by histoincompatible cells expressing interleukin-2. Int. Imm., 4, 1429-1436.
13. Schmidt-Wolf, G. & Schmidt-Wolf, I.G.H. (1995), Cytokines and clinical gene therapy. Eur. J. Immunol., 25, 1137-1140.
14. Thielen, G.H. & Madewell, B.R. (1987), Feline fibrosarcoma, in "Veterinary cancer medicine, 2nd ed." (G.H. Theilen & B.R. Madewell) (pp. 382-391). Lea & Febiger, Philadelphia.
15. + T cells by B7-transfected melanoma cells. Science, 259, 368-370.
16. Van Der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van Den Eynde, B., Knuth, A. & Boon, T. (1991), A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma. Science, 254, 1643-1647.
17. Wallich, R., Bulbuc, N., Hammerling, G., Katsav, S., Segal, S. & Feldman, M. (1985), Abrogation of metastatic properties of tumor cells by de novo expression of H2-K antigens following H2 gene transfection. Nature, 315, 301-305.
18. Whartenby, K.A., Abraham, G.N., Calabresi, P.A., Abboud, C.N., Catabresi, P., Marrogi, A. & Freeman, S.M. (1995), Gene-modified cells for the treatment of cancer. Pharmac. Ther., 66, 175-190.